1ª Conferência Nacional de Vigilância em Saúde é adiada
http://portal.anvisa.gov.br/web/guest/rss/-/asset_publisher/Zk4q6UQCj9Pn/content/id/3766519
http://portal.anvisa.gov.br/web/guest/rss/-/asset_publisher/Zk4q6UQCj9Pn/content/id/3766519
http://portal.anvisa.gov.br/web/guest/rss/-/asset_publisher/Zk4q6UQCj9Pn/content/id/3764231
The European Medicines Agency (EMA) has launched today a new and improved version of EudraVigilance, the European information system of suspected adverse reactions to medicines that are authorised or being studied in clinical trials in the European Economic Area (EEA). The new system makes it easier for marketing authorisation holders and sponsors of clinical trials to report suspected adverse reactions and allows for better analysis of this information for the benefit of patient safety in Europe.
For more information go to EudraVigilance
RedETSA and the Pan-American Health Organization (PAHO) are launching the Regional Base of Health Technology Assessment Reports of the Americas – BRISA. This tool will allow the search of Health Technologies Assessment (HTA) bibliography produced by 33 member organizations of the Network. Initially, the base will include around 600 reports in Spanish, Portuguese, French, and English
This initiative, pioneer in Americas, was made in partnership with BIREME (Centro Latino-Americano e do Caribe de Informação em Ciência da Saúde), through BVS (Bibioteca Virtual em Saúde). BVS will host the database, which enables crossing- searching the researched subject with other available databases, such as LILACS and Medline.
With the launching of BRISA, PAHO and RedETSA aim to promote the use of HTA to improve the decision making process for the incorporation of technologies in the health systems.
BRISA is avalilabe at http://sites.bvsalud.org/redetsa/brisa/